Medgenics, Inc. (MDGN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.98+0.10 (+2.05%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close4.88
Bid4.80 x 400
Ask5.49 x 500
Day's Range4.89 - 5.11
52wk Range3.09 - 7.57
1y Target EstN/A
Market Cap184.65M
P/E Ratio (ttm)-3.36
Avg Vol (3m)115,135
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Marketwired2 days ago

    Medgenics to Host Conference Call to Announce Third Quarter 2016 Financial Results

    Medgenics, Inc. will host a conference call and live audio webcast on Thursday, November 3, 2016 at 8:30 a.m. EST to report financial results for the third quarter ended September 30, 2016 and discuss ...

  • American City Business Journals16 days ago

    Main Line gene therapy company is trading exchanges

    Medgenics is switching stock exchanges. The Wayne, Pennsylvania, gene therapy company’s application to have its stock listed on the NASDAQ Global Market has been approved. MedGenics stock was previously traded on the NYSEMKT exchange, formerly known as the American Stock Exchange.

  • Marketwired18 days ago

    Medgenics, Inc. to Begin Trading on NASDAQ Global Market

    Medgenics, Inc. announced today that it has been approved for listing on the NASDAQ Global Market, continuing to trade under the symbol "MDGN." Trading on the NASDAQ Global Market is expected ...